SAFETY AND EARLY DATA FROM A PHASE II TRIAL OF PEMBROLIZUMAB (PEM) AND ENTINOSTAT (ENT) IN RELAPSED AND REFRACTORY (R/R) HODGKIN LYMPHOMA (HL) AND FOLLICULAR LYMPHOMA (FL)
Autor: | Connie W. Batlevi, Ahmet Dogan, Joachim Yahalom, Anas Younes, M. Matasar, Erin Biggar, Santosha Vardhana, Audrey Hamilton, E. Leung, Chaya S. Moskowitz, David Sermer, Philip Caron, Venkatraman E. Seshan, A.J. Moskowitz, Jürgen Rademaker |
---|---|
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | Hematological Oncology. 37:331-332 |
ISSN: | 0278-0232 |
Databáze: | OpenAIRE |
Externí odkaz: |